Literature DB >> 30530777

CapTCR-seq: hybrid capture for T-cell receptor repertoire profiling.

David T Mulder1, Etienne R Mahé2, Mark Dowar1, Youstina Hanna1, Tiantian Li1, Linh T Nguyen1, Marcus O Butler1, Naoto Hirano1,3,4, Jan Delabie5, Pamela S Ohashi1,3,6, Trevor J Pugh1,4,6.   

Abstract

Mature T-cell lymphomas consisting of an expanded clonal population of T cells that possess common rearrangements of the T-cell receptor (TCR) encoding genes can be identified and monitored using molecular methods of T-cell repertoire analysis. We have developed a hybrid-capture method that enriches DNA sequencing libraries for fragments encoding rearranged TCR genes from all 4 loci in a single reaction. We use this method to describe the TCR repertoires of 63 putative lymphoma clinical isolates, 7 peripheral blood mononuclear cell (PBMC) populations, and a collection of tumor infiltrating lymphocytes. Dominant Variable (V) and Joining (J) gene pair rearrangements in cancer cells were confirmed by polymerase chain reaction (PCR) amplification and Sanger sequencing; clonality assessment of clinical isolates using BIOMED-2 methods showed agreement for 73% and 77% of samples at the β and γ loci, respectively, whereas β locus V and J allele prevalence in PBMCs were well correlated with results from commercial PCR-based DNA sequencing assays (r 2 = 0.94 with Adaptive ImmunoSEQ, 0.77-0.83 with Invivoscribe LymphoTrack TRB Assay). CapTCR-seq allows for rapid, high-throughput and flexible characterization of dominant clones within TCR repertoire that will facilitate quantitative analysis of patient samples and enhance sensitivity of tumor surveillance over time.
© 2018 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30530777      PMCID: PMC6290103          DOI: 10.1182/bloodadvances.2017014639

Source DB:  PubMed          Journal:  Blood Adv        ISSN: 2473-9529


  27 in total

Review 1.  Target-enrichment strategies for next-generation sequencing.

Authors:  Lira Mamanova; Alison J Coffey; Carol E Scott; Iwanka Kozarewa; Emily H Turner; Akash Kumar; Eleanor Howard; Jay Shendure; Daniel J Turner
Journal:  Nat Methods       Date:  2010-02       Impact factor: 28.547

2.  MiTCR: software for T-cell receptor sequencing data analysis.

Authors:  Dmitriy A Bolotin; Mikhail Shugay; Ilgar Z Mamedov; Ekaterina V Putintseva; Maria A Turchaninova; Ivan V Zvyagin; Olga V Britanova; Dmitriy M Chudakov
Journal:  Nat Methods       Date:  2013-07-28       Impact factor: 28.547

3.  Human T-cell lines with well-defined T-cell receptor gene rearrangements as controls for the BIOMED-2 multiplex polymerase chain reaction tubes.

Authors:  Y Sandberg; B Verhaaf; E J van Gastel-Mol; I L M Wolvers-Tettero; J de Vos; R A F Macleod; J G Noordzij; W A Dik; J J M van Dongen; A W Langerak
Journal:  Leukemia       Date:  2006-12-14       Impact factor: 11.528

4.  MiXCR: software for comprehensive adaptive immunity profiling.

Authors:  Dmitriy A Bolotin; Stanislav Poslavsky; Igor Mitrophanov; Mikhail Shugay; Ilgar Z Mamedov; Ekaterina V Putintseva; Dmitriy M Chudakov
Journal:  Nat Methods       Date:  2015-05       Impact factor: 28.547

5.  Decombinator: a tool for fast, efficient gene assignment in T-cell receptor sequences using a finite state machine.

Authors:  Niclas Thomas; James Heather; Wilfred Ndifon; John Shawe-Taylor; Benjamin Chain
Journal:  Bioinformatics       Date:  2013-01-09       Impact factor: 6.937

Review 6.  Regulatory and effector functions of gamma-delta (γδ) T cells and their therapeutic potential in adoptive cellular therapy for cancer.

Authors:  Sourav Paul; Girdhari Lal
Journal:  Int J Cancer       Date:  2016-04-15       Impact factor: 7.396

Review 7.  Mechanics of T cell receptor gene rearrangement.

Authors:  Michael S Krangel
Journal:  Curr Opin Immunol       Date:  2009-04-09       Impact factor: 7.486

Review 8.  γδ T cells in cancer.

Authors:  Bruno Silva-Santos; Karine Serre; Håkan Norell
Journal:  Nat Rev Immunol       Date:  2015-10-09       Impact factor: 53.106

Review 9.  The many important facets of T-cell repertoire diversity.

Authors:  Janko Nikolich-Zugich; Mark K Slifka; Ilhem Messaoudi
Journal:  Nat Rev Immunol       Date:  2004-02       Impact factor: 53.106

10.  PEAR: a fast and accurate Illumina Paired-End reAd mergeR.

Authors:  Jiajie Zhang; Kassian Kobert; Tomáš Flouri; Alexandros Stamatakis
Journal:  Bioinformatics       Date:  2013-10-18       Impact factor: 6.937

View more
  3 in total

1.  Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus-Unrelated Head and Neck Cancer: A Multicenter, Phase II Trial.

Authors:  Ravindra Uppaluri; Katie M Campbell; Obi L Griffith; Douglas R Adkins; Ann Marie Egloff; Paul Zolkind; Zachary L Skidmore; Brian Nussenbaum; Randal C Paniello; Jason T Rich; Ryan Jackson; Patrik Pipkorn; Loren S Michel; Jessica Ley; Peter Oppelt; Gavin P Dunn; Erica K Barnell; Nicholas C Spies; Tianxiang Lin; Tiantian Li; David T Mulder; Youstina Hanna; Iulia Cirlan; Trevor J Pugh; Tenny Mudianto; Rachel Riley; Liye Zhou; Vickie Y Jo; Matthew D Stachler; Glenn J Hanna; Jason Kass; Robert Haddad; Jonathan D Schoenfeld; Evisa Gjini; Ana Lako; Wade Thorstad; Hiram A Gay; Mackenzie Daly; Scott J Rodig; Ian S Hagemann; Dorina Kallogjeri; Jay F Piccirillo; Rebecca D Chernock; Malachi Griffith
Journal:  Clin Cancer Res       Date:  2020-07-14       Impact factor: 12.531

Review 2.  Utility of Bulk T-Cell Receptor Repertoire Sequencing Analysis in Understanding Immune Responses to COVID-19.

Authors:  Hannah Kockelbergh; Shelley Evans; Tong Deng; Ella Clyne; Anna Kyriakidou; Andreas Economou; Kim Ngan Luu Hoang; Stephen Woodmansey; Andrew Foers; Anna Fowler; Elizabeth J Soilleux
Journal:  Diagnostics (Basel)       Date:  2022-05-13

3.  Genomic predictors of response to PD-1 inhibition in children with germline DNA replication repair deficiency.

Authors:  Anirban Das; Sumedha Sudhaman; Daniel Morgenstern; Ailish Coblentz; Jiil Chung; Simone C Stone; Noor Alsafwani; Zhihui Amy Liu; Ola Abu Al Karsaneh; Shirin Soleimani; Hagay Ladany; David Chen; Matthew Zatzman; Vanja Cabric; Liana Nobre; Vanessa Bianchi; Melissa Edwards; Lauren C Sambira Nahum; Ayse B Ercan; Arash Nabbi; Shlomi Constantini; Rina Dvir; Michal Yalon-Oren; Gadi Abebe Campino; Shani Caspi; Valerie Larouche; Alyssa Reddy; Michael Osborn; Gary Mason; Scott Lindhorst; Annika Bronsema; Vanan Magimairajan; Enrico Opocher; Rebecca Loret De Mola; Magnus Sabel; Charlotta Frojd; David Sumerauer; David Samuel; Kristina Cole; Stefano Chiaravalli; Maura Massimino; Patrick Tomboc; David S Ziegler; Ben George; An Van Damme; Nobuko Hijiya; David Gass; Rose B McGee; Oz Mordechai; Daniel C Bowers; Theodore W Laetsch; Alexander Lossos; Deborah T Blumenthal; Tomasz Sarosiek; Lee Yi Yen; Jeffrey Knipstein; Anne Bendel; Lindsey M Hoffman; Sandra Luna-Fineman; Stefanie Zimmermann; Isabelle Scheers; Kim E Nichols; Michal Zapotocky; Jordan R Hansford; John M Maris; Peter Dirks; Michael D Taylor; Abhaya V Kulkarni; Manohar Shroff; Derek S Tsang; Anita Villani; Wei Xu; Melyssa Aronson; Carol Durno; Adam Shlien; David Malkin; Gad Getz; Yosef E Maruvka; Pamela S Ohashi; Cynthia Hawkins; Trevor J Pugh; Eric Bouffet; Uri Tabori
Journal:  Nat Med       Date:  2022-01-06       Impact factor: 87.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.